1
Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Condition(s):Breast CancerLast Updated:May 14, 2021Completed
Fulvestrant: 384 Clinical Trials, Page 1 of 39
Hide Studies Not Open or Pending
2
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
Condition(s):Breast CancerLast Updated:July 16, 2021Recruiting
3
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Condition(s):Locally Advanced or Metastatic Breast CancerLast Updated:September 29, 2021Not yet recruiting
4
A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Condition(s):Female Breast Carcinoma; Female Ductal Carcinoma In SituLast Updated:August 18, 2020Terminated
5
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Condition(s):Advanced Breast CancerLast Updated:April 19, 2021Recruiting
6
Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:November 30, 2020Recruiting
7
Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.
Condition(s):Postmenopausal Women With ER+ HER2- Primary Breast CancerLast Updated:February 6, 2020Completed
8
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Condition(s):ER-positive Breast Cancer; HER2-negative Breast Cancer; Metastatic CancerLast Updated:September 21, 2021Recruiting
9
Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Condition(s):Breast CancerLast Updated:May 24, 2021Not yet recruiting
10
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Condition(s):Breast CancerLast Updated:September 9, 2021Active, not recruiting